Mensuração e evidenciação de ativos biológicos por empresas listadas

• Autor(a) principal: Rodrigues, Suzane Vieira Borges
• Data de Publicação: 2017
• Tipo de documento: Trabalho de conclusão de curso
• Idioma: por
• Título da fonte: Repositório Institucional da UFU
• Texto Completo: https://repositorio.ufu.br/handle/123456789/20117
• topic: Ativos biológicos.; Mensuração.; Valor Justo.; Biological Assets.; Measurement.; Fair value.; CNPQ::CIENCIAS SOCIAIS APLICADAS::ADMINISTRACAO::CIENCIAS CONTABEIS

This study aimed to present the accounting disclosure of biological assets by companies listed on the B3. It selected the non-cyclical consumption sector, sub-sectors Agricultural and Processed Food the most likely to present such assets. The general objective was to verify if the sample companies fully evidence the information about the biological assets as established by the legislation. In particular, check how the measurement is made of the fair value of these assets in accordance with CPC 29 - Biological Assets and Agricultural Products by selected companies. To do so, a checklist was applied, based on the guidelines on the disclosure of CPC 29 on the financial statements for the 2016 financial year of the sample companies, in an attempt to corroborate the hypothesis that companies conformed to the new standard. This is a descriptive, qualitative and documentary research. The sample consisted of 11 companies from 20 industry because they contain biological active in the composition of their balance sheets. As results, it was verified that the most widely used method to measure fair value is by its market price. It was concluded that not all companies are fully complying with the proposed technical pronouncement, mainly regarding the assumptions used for such measurement. There is also a lack of relevant information in the explanatory notes of some companies.